Express News | Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at Escmid Global 2024 Scientific Conference
ReutersMay 2 07:00 ET
Express News | Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at Upcoming Escmid 2024 Scientific Conference
ReutersApr 25 10:12 ET
Express News | Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update
Moomoo 24/7Apr 23 10:57 ET
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Alcoa Corporation (NYSE:AA) rose sharply in today's pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of
BenzingaApr 18 06:28 ET
Acurx Pharmaceuticals Withdraws Filing for Stock Offering
Acurx Pharmaceuticals Withdraws Filing for Stock Offering
Dow JonesApr 17 16:09 ET
Top Premarket Gainers
HWH International (HWH) shares soared 60% Thursday premarket following a 2% gain in the previous session. Tevogen Bio Holdings (TVGN) shares surged more than 100%, rebounding from Wednesday's losses.
MT NewswiresApr 4 07:37 ET
Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV
Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofit
newsfileMar 21 07:01 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOntrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN)
BenzingaMar 19 13:31 ET
Acurx Files Common Stock Offering, No Amount Given
Seeking AlphaMar 19 10:23 ET
Graphite Bio, SCWorx, Acurx Pharmaceuticals Among Healthcare Movers
Seeking AlphaMar 19 10:00 ET
H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating
H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating.
MT NewswiresMar 19 09:32 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersOntrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. The company's market cap stands at $14.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN) shares rose 97.46% t
BenzingaMar 19 09:05 ET
US Futures Trend Lower in Tuesday's Premarket as Investors Await Start of 2-Day Fed Meeting
US stock futures were trending lower in Tuesday's premarket session ahead of the Federal Reserve's two-day policy meeting, which begins later in the day. The Dow Jones Industrial Average futures were
MT NewswiresMar 19 08:07 ET
Acurx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Acurx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 19 06:42 ET
Express News | HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12
Moomoo 24/7Mar 19 06:32 ET
Acurx Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/19/2024 531.58% HC Wainwright & Co. $14 → $12 Maintains Buy 02/28/2024 636.84% HC Wainwright & Co. → $1
BenzingaMar 19 06:27 ET
Acurx Pharmaceuticals: Strong Buy on Ibezapolstat's Promising Phase 3 Trials and Strategic Partnerships
TipRanksMar 19 06:26 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersOntrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. The company's market cap stands at $8.4 million. Universe Pharmaceuticals (NASDAQ:UPC) stock rose 30
BenzingaMar 18 17:33 ET
Express News | Acurx Pharmaceuticals Shares Are Trading Lower After the Company Filed for a Common Stock Offering
Moomoo 24/7Mar 18 16:35 ET
Express News | Acurx Pharmaceuticals Inc Files For Common Stock Offering; Size Not Disclosed
Moomoo 24/7Mar 18 16:08 ET
No Data
No Data